Position covers Dallas, Oklahoma, Missouri, Arkansas, and Kansas. Ideal location would be Dallas, TX or Oklahoma City, OK.
About Krystal Bio:
At Krystal Biotech, Inc., we bring together the brightest and most eager minds to relentlessly pursue the discovery, development and delivery of transformative medicines for people with serious and life-threatening genetic diseases. Founded in 2016, the Company is the leader in redosable gene therapy with prominent commercial, clinical and pre-clinical stage programs for dystrophic epidermolysis bullosa, TGM1-deficient ARCI, Netherton Syndrome, Cystic Fibrosis, alpha-1 antitrypsin deficiency, and is advancing research to apply our technology to these and other diseases. The Company’s innovation is fueled by visionary leadership within an entrepreneurial organizational structure with a robust pipeline of investigational medicine.
Our US headquarters is in Pittsburgh, PA with other offices located in Boston, MA and in Zug, Switzerland. For more information about the Company’s platform, commitment to patients and pipeline, please visit http://www.krystalbio.com and engage with us on Twitter and LinkedIn.
We have an exciting journey ahead and a tremendous opportunity for growth, and now is the time to make a meaningful impact on the lives of our patients!
Job Description Summary:
The Regional Gene Therapy Consultant (RGTC) will be a self-starter, who places an extremely high value on accountability as it relates to themselves and the team. This person is an innovative sales professional who is very patient-centric and utilizes their role to build trust with both internal and external stakeholders. The RGTC will be promoting Vyjuvek for the treatment of patients with dystrophic epidermolysis bullosa (DEB). Vyjuvek is a non-invasive, topical gene therapy designed to treat DEB at the molecular level by providing the patient’s skin cells with two copies of the COL7A1 gene to make functional COL7 protein, thereby addressing the fundamental disease-causing mechanism. The RGTC will be responsible for the successful launch of the first commercialized product for the company within their given territory. They will represent the “voice of the customer” with other members of the Krystal Team. They will also bring passion to the Dermatology Community as well as other specialties that diagnose, treat, and manage DEB.
We are looking for a creative sales professional who can work as an individual while contributing to the team and sharing ideas to facilitate a successful launch. Krystal employees are expected to embrace diversity and be able to work with internal and external partners from a variety of backgrounds and experiences. Additionally, the successful candidate must demonstrate excellence in integrity and compliance with all interactions and adherence to corporate and industry guidelines. Krystal offers a fun, friendly and industry-competitive environment.
Our Gene Therapy Team is committed to improving the lives of patient with rare skin diseases. The Regional Gene Therapy Consultant is a key member of our customer-facing field organization and is responsible for partnering with key customers to address and identify needs, while compliantly educating key stakeholders about our product--which will potentially be the first therapy approved for DEB. Base salary for this position ranges from $185,000-$215,000 with a target bonus of $15,000 per quarter.
Specific responsibilities include but are not limited to:
Experience and Skills Desired:
Krystal Biotech, Inc. is an Equal Employment Opportunity and Affirmative Action Employers. Qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender perception or identity, national origin, age, marital status, protected veteran status, or disability status. Headhunters and recruitment agencies may not submit resumes/CVs through this Web site or directly to managers. Krystal Biotech, Inc. does not accept unsolicited headhunter and agency resumes. Krystal Biotech, Inc. will not pay fees to any third-party agency or company that does not have a signed agreement with Krystal Biotech, Inc.
Veeva Systems
Wipfli
Mazars
Metasys Technologies
Veeva Systems